Modélisation de l’impact économique d’un dépistage organisé du cancer du poumon en France

Incidence et mortalité nationales du cancer du poumon [Internet]. Site officiel de l’Institut national du cancer. 2015. Available from: http://lesdonnees.e-cancer.fr/les-fiches-de-synthese/1-types-cancer/12-cancer-poumon/30-epidemiologie-cancer-poumon-france-metropolitaine-incidence-mortalite.html. [cited 2015 Jul 27]. Locher, 2013, Major changes in lung cancer over the last 10 years in France: the KBP-CPHG studies, Lung Cancer, 81, 32, 10.1016/j.lungcan.2013.03.001 Debieuvre, 2014, Évolution en 10ans du cancer bronchique non à petites cellules en fonction du sexe. Résultats de l’étude KBP-2010-CPHG du Collège des pneumologues des hôpitaux généraux, Rev Mal Respir, 31, 805, 10.1016/j.rmr.2013.10.644 Couraud, 2012, Lung cancer in never smokers – a review, Eur J Cancer, 48, 1299, 10.1016/j.ejca.2012.03.007 Goldstraw, 2007, The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours, J Thorac Oncol, 2, 706, 10.1097/JTO.0b013e31812f3c1a Henschke, 2006, Survival of patients with stage I lung cancer detected on CT screening, N Engl J Med, 355, 1763, 10.1056/NEJMoa060476 Raz, 2007, Natural history of stage I non-small cell lung cancer: implications for early detection, Chest, 132, 193, 10.1378/chest.06-3096 Wilson, 1970 Oken, 2011, Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial, JAMA, 306, 1865, 10.1001/jama.2011.1591 Aberle, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873 Couraud, 2013, Ann Oncol, 24, 586, 10.1093/annonc/mds476 Horeweg, 2013, Volumetric computed tomography screening for lung cancer: three rounds of the Nelson trial, Eur Respir J, 42, 1659, 10.1183/09031936.00197712 van Klaveren, 2009, Management of lung nodules detected by volume CT scanning, N Engl J Med, 361, 2221, 10.1056/NEJMoa0906085 Horeweg, 2013, Characteristics of lung cancers detected by computer tomography screening in the randomized Nelson trial, Am J Respir Crit Care Med, 187, A2342, 10.1164/rccm.201209-1651OC Horeweg, 2014, Detection of lung cancer through low-dose CT screening (Nelson): a prespecified analysis of screening test performance and interval cancers, Lancet Oncol, 15, 1342, 10.1016/S1470-2045(14)70387-0 Field, 2013, European randomized lung cancer screening trials: Post NLST: European Randomized Lung Cancer Screening Trials, J Surg Oncol, 108, 280, 10.1002/jso.23383 Girard, 2014, Le dépistage individuel du cancer bronchopulmonaire en pratique. Perspectives sur les propositions du groupe de travail pluridisciplinaire de l’Intergroupe francophone de cancérologie thoracique et du groupe d’oncologie de langue française, Rev Mal Respir, 31, 91, 10.1016/j.rmr.2013.10.641 2014, 39 2015 2005 von Karsa, 2013, European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication, Endoscopy, 45, 51 Taux de participation au Programme national du dépistage organisé du cancer colorectal [Internet]. Site oficiel de l’Institut national du cancer. Available from: http://lesdonnees.e-cancer.fr/les-fiches-de-synthese/23-depistage/48-depistage-cancer-colorectal/59-taux-participation-depistage-organise-cancer-colorectal.html. [cited 2015 Jul 27]. Amalric, 2007, 146 2015 Goulart, 2012, Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness, J Natl Compr Cancer Netw, 10, 267, 10.6004/jnccn.2012.0023 Black, 2014, Cost-effectiveness of CT screening in the National Lung Screening Trial, N Engl J Med, 371, 1793, 10.1056/NEJMoa1312547 Pyenson, 2012, An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood), 31, 770 Manser, 2005, Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting, Lung Cancer, 48, 171, 10.1016/j.lungcan.2004.11.001 Cressman, 2014, Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada, J Thorac Oncol, 9, 1449, 10.1097/JTO.0000000000000283 Shmueli, 2013, Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience, Value Health, 16, 922, 10.1016/j.jval.2013.05.007 Villanti, 2013, A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions, PLoS One, 8, e71379, 10.1371/journal.pone.0071379 Carreras, 2012, Can a national lung cancer screening program in combination with smoking cessation policies cause an early decrease in tobacco deaths in Italy?, Cancer Prev Res, 5, 874, 10.1158/1940-6207.CAPR-12-0019 McMahon, 2011, Cost-effectiveness of computed tomography screening for lung cancer in the United States, J Thorac Oncol, 6, 1841, 10.1097/JTO.0b013e31822e59b3 Silvestri, 2007, Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts, Thorax, 62, 126, 10.1136/thx.2005.056036 Blanchon, 2007, Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR), Lung Cancer, 58, 50, 10.1016/j.lungcan.2007.05.009 Grogan, 2011, Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease, J Thorac Oncol, 6, 1720, 10.1097/JTO.0b013e318226b48a Pinsky, 2013, The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology, Cancer, 119, 3976, 10.1002/cncr.28326 de Koning, 2014, Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force, Ann Intern Med, 160, 311, 10.7326/M13-2316